IP Library › Granted Patent US 6,850,795
Granted Patent B2
US 6,850,795 · App. 10/339,546 · Granted Feb 1, 2005

Method of noninvasively determining a patient's susceptibility to arrhythmia

Assignee: Harbinger Medical, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,850,795
App. No.
10/339,546
Granted
Feb 1, 2005
Kind
B2
Abstract

A system and method for detecting a patient's susceptibility to arrhythmias and cardiac tissue abnormality is disclosed. The method consists of using a computer 27 , a display 23 , software loaded onto the computer that generates graphical user interfaces (GUIs), an electronic interface 18 , and a plurality of electrodes. The electronics interface 18 is in electronic communication with the computer 27 , and further in electronic communication with the electrodes that are placed by self-adhesion at predetermined locations on a test subject 35 . According to one aspect of the invention, the method enables a user, typically a medical professional, to initiate, with minimal input, certain diagnostic tests involving observing and analyzing a series of QRS complexes 130 , some of which are biased with a subpacing current, and others of which are unbiased. The signals are then compared, and the differences are analyzed to detect a patient's susceptibility to arrhythmias and cardiac tissue abnormality.

Claims (5)

1. A method for detecting patient susceptibility to arrhythmias comprising the steps of:

providing means for injecting low level electromagnetic energy stimulations into a patient's body suitable to alter at least one cardiac signal to allow a comparison of acquired distinguishable signal differences with at least one other cardiac signal which has not been affected by said injected energy;

connecting a lead system for both sensing the cardiac signals and delivering the injected energy to said means for injecting low level electromagnetic energy into the patient's body, said lead system, comprising a plurality of energy sensing and energy delivery leads and a plurality of energy sensing and energy delivery electrodes;

utilizing sensing improvement means for improving the quality of the sensed electromagnetic energy during the stimulation and acquisition process; and

evaluating the sensed signal for one or more arrhythmia predictive factors by evaluating variability over multiple QRST complexes by evaluating the relative timing of any combination of P-wave, Q-wave, R-wave, S-wave, or T-wave in a single QRST complex.

Assignments (2)
LIEN Recorded Nov 4, 2011
From: HARBINGER MEDICAL, INC.
To: PATTERSON THUENTE CHRISTENSEN PEDERSEN, P.A.
Reel/Frame 027174/0205 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER PREVIOUSLY RECORDED ON REEL 023085 FRAME 0304. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD BE: 6,850,795. Recorded Sep 25, 2009
From: HOIUM, HAROLD H; RYAN, STEPHEN J; MALIK, MAREK
To: HARBINGER MEDICAL, INC.
Reel/Frame 023282/0159 →
Continuity (5)
Continuation 0959096500 · Jun 9, 2000
Provisional Application 6019102900 · Mar 21, 2000
Provisional Application 6013849700 · Jun 10, 1999
Provisional Application 6013843900 · Jun 10, 1999
Related Publication 20030139678A1 · Jul 24, 2003